Literature DB >> 2810265

Septic arthritis due to Mycobacterium phlei presenting as infantile Reiter's syndrome.

J L Aguilar1, E E Sanchez, C Carrillo, G S Alarcón, A Silicani.   

Abstract

We describe a 7-year-old Peruvian boy who presented with a 2 week history of conjunctivitis, urethritis and arthritis, in whom Mycobacterium phlei was the only organism repeatedly isolated from synovial fluid and tissue and who responded to conventional antituberculous therapy. To our knowledge this is the first documented case of human disease caused by this microorganism.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2810265

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

1.  Large-scale production of coenzyme F420-5,6 by using Mycobacterium smegmatis.

Authors:  Dale Isabelle; D Randall Simpson; Lacy Daniels
Journal:  Appl Environ Microbiol       Date:  2002-11       Impact factor: 4.792

2.  Complete genome sequence of Mycobacterium phlei type strain RIVM601174.

Authors:  Abdallah M Abdallah; Mamoon Rashid; Sabir A Adroub; Marc Arnoux; Shahjahan Ali; Dick van Soolingen; Wilbert Bitter; Arnab Pain
Journal:  J Bacteriol       Date:  2012-06       Impact factor: 3.490

3.  "Mycobacterium massilipolynesiensis" sp. nov., a rapidly-growing mycobacterium of medical interest related to Mycobacterium phlei.

Authors:  M Phelippeau; S Asmar; D Aboubaker Osman; M Sassi; C Robert; C Michelle; D Musso; M Drancourt
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

4.  Mycobacterium phlei Vertebral Osteomyelitis.

Authors:  Alan W McGee; Chase S Dean; Ashley Ignatiuk; Carla Savelli; Christopher J Kleck
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2019-12-05

5.  The Mycobacterium phlei Genome: Expectations and Surprises.

Authors:  Sarbashis Das; B M Fredrik Pettersson; Phani Rama Krishna Behra; Malavika Ramesh; Santanu Dasgupta; Alok Bhattacharya; Leif A Kirsebom
Journal:  Genome Biol Evol       Date:  2016-04-08       Impact factor: 3.416

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.